Humabs BioMed AG

At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.

Cureline AG belongs to Cureline Group, precision medicine CRO of Californian origin and global reach. In 20 years of its history, Cureline Group became a best-in-class expert in oncology human sample validation studies (HBS biobanking), in vitro and animal testing. New venture: ATMP CDMO (EU).

Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics. Established in 2003, MBH's mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies. Our Q system complies with AIFA/EU GMP requirements.